How to Evaluate Peptide Claims and Clinic Marketing

Why peptide marketing needs a closer look

Peptide products are promoted with words like "regenerative", "anti-aging" and "clinically studied". Some claims rest on an approved medicine used as labeled. Many rest on cell or animal research. This page gives a short way to sort them. It does not recommend any product, clinic or treatment, and it cannot tell you whether a particular product is safe. Regulatory statements below name the country (the United States unless stated), the product and the official page, and were read on 2026-10-22.

Question 2: What kind of evidence is being quoted?

Preclinical research (cells and animals) asks whether a drug might cause serious harm before people receive it. FDA says it is not a substitute for studies in people. [4][5] Phase 1 studies mainly look at safety and dosage; Phase 2 studies look at efficacy and side effects in people with the condition; Phase 3 studies are larger. [5] A hormone level rising, or an animal healing faster, is not the same as a person feeling or functioning better. A review of growth hormone secretagogues, for example, concluded that few long-term, rigorously controlled studies have examined their efficacy and safety. [6] Use the labels on how we label evidence and read early-stage research for the difference between study types.

Question 3: Is a trial registration being treated as a result?

A registry record is a plan or a status, not a finding. WHO describes trial registration as publication of agreed information about the design, conduct and administration of a trial. [7] A systematic review found that about 54% of studies in trial registries were published as journal articles (pooled estimate, with very wide variation), and that non-publication is associated with the direction of findings. [8] See clinical trials for peptides.

Question 4: Is the label doing the work?

"Research use only" and "not for human consumption" labels do not decide how FDA treats a product. In a warning letter to one US seller, FDA said evidence from the website established that products carrying such statements were drugs intended for human use. [9] "Compounded" does not mean approved: FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. [10] See compounded medicines.

Question 5: Who is selling, and what do they gain?

MedlinePlus advises asking who runs a site and who pays for it, because if a business pays for the site the information may favor that business and its products. It also advises beware of dramatic writing, promises of cures and claims that sound too good to be true. [11] Testimonials and before-and-after photos are marketing claims, not studies.

Quick table

Before you decide

Bring the product name, the claim and any paperwork to a licensed clinician or pharmacist who is not selling it. See talking with a health professional and evaluating safety claims. For known risks, read peptide safety and adverse events.